As of 2024-12-13, the Relative Valuation of PTC Therapeutics Inc (PTCT) is (125.45) USD. This relative valuation is based on P/E multiples. With the latest stock price at 49.67 USD, the upside of PTC Therapeutics Inc based on Relative Valuation is -352.6%.
The range of the Relative Valuation is (118.34) - (138.67) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.8x - 24.8x | 20.8x |
| Forward P/E multiples | 20.1x - 23.6x | 21.9x |
| Fair Price | (118.34) - (138.67) | (125.45) |
| Upside | -338.2% - -379.2% | -352.6% |
| Date | P/E |
| 2024-12-11 | -8.45 |
| 2024-12-10 | -8.51 |
| 2024-12-09 | -8.18 |
| 2024-12-06 | -8.18 |
| 2024-12-05 | -8.24 |
| 2024-12-04 | -8.49 |
| 2024-12-03 | -8.56 |
| 2024-12-02 | -8.86 |
| 2024-11-29 | -7.47 |
| 2024-11-27 | -7.68 |
| 2024-11-26 | -7.83 |
| 2024-11-25 | -7.32 |
| 2024-11-22 | -7.36 |
| 2024-11-21 | -7.30 |
| 2024-11-20 | -7.14 |
| 2024-11-19 | -6.70 |
| 2024-11-18 | -6.68 |
| 2024-11-15 | -6.68 |
| 2024-11-14 | -7.21 |
| 2024-11-13 | -7.49 |
| 2024-11-12 | -7.59 |
| 2024-11-11 | -7.64 |
| 2024-11-08 | -7.54 |
| 2024-11-07 | -7.31 |
| 2024-11-06 | -7.35 |
| 2024-11-05 | -6.96 |
| 2024-11-04 | -6.87 |
| 2024-11-01 | -6.89 |
| 2024-10-31 | -6.79 |
| 2024-10-30 | -6.92 |
| 2024-10-29 | -7.23 |
| 2024-10-28 | -6.89 |
| 2024-10-25 | -6.94 |
| 2024-10-24 | -7.05 |
| 2024-10-23 | -7.23 |
| 2024-10-22 | -6.69 |
| 2024-10-21 | -6.54 |
| 2024-10-18 | -6.65 |
| 2024-10-17 | -6.30 |
| 2024-10-16 | -6.25 |
| 2024-10-15 | -6.39 |
| 2024-10-14 | -6.66 |
| 2024-10-11 | -6.64 |
| 2024-10-10 | -6.55 |
| 2024-10-09 | -6.80 |
| 2024-10-08 | -6.94 |
| 2024-10-07 | -5.95 |
| 2024-10-04 | -5.97 |
| 2024-10-03 | -6.02 |
| 2024-10-02 | -6.20 |